India to Us Virgin Islands Pharmaceutical Export (2026) — $7.0K, 1 Suppliers | TransData Nexus

India to Us Virgin Islands Pharmaceutical Export (2026) — $7.0K, 1 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Us Virgin Islands

#	Formulation	Value	Share
1	Metrogyl O Tablets (box) (10x10tab) Metronidazole Batch No. Aod25001	$905	12.9%
2	Candizest Ct Softgels Box 10x7 Capsules Clindamycin Cotrimoxazole Batch No Cd 2…	$712	10.1%
3	Carvediol Cr-20 (20x10tab) Carvedilol Batch No. T241447	$530	7.5%
4	Cartizest 500mg (box) (10x10tab) Gluosamine Sulphate Batch No. Crst-015	$493	7.0%
5	Lignogesic Gel (30gm) Topical Pain Reliever Batch No. E50054	$414	5.9%
6	Flavonown 500mg 10x10 Tablets Flavonoidbatch No St 241635	$391	5.6%
7	Gabimax 300 Capsule (box) (10x10cap) Ganprntine Batch No. Dc503010	$382	5.4%
8	Predzest 4mg (box) (10x10tab) Methylprednisolone Batch No. Pz4t-053	$364	5.2%
9	Doxyford 100 Box 20 X 10 Capsules Doxycycline Hydrochloride Batch No C250075	$290	4.1%
10	Benlevo 500mg Box 10x10tab Levofloxacin Batch No Blvt 047	$271	3.8%
11	Oviva 369 Capsules (10x10 Capsules) Factty Acids Batch No. Cd-241215c	$261	3.7%
12	Lindazycin 150mg Box 10x10 Capsules Clindamycin Batch No Bd242663	$258	3.7%
13	Rapiglinide Vog 1 0 10 X 10 Tablets Repaglinide Voglibose Batch No Ybbh05	$193	2.7%
14	Benlevo 750mg Box 10x10 Tablets Levofloxacin Batch No Blvt 021	$179	2.5%
15	Glycirest Sr 500mg Box 10x10 Tablets Metformin Hydrochloride Batch No Gtst 048	$172	2.4%

India exports 20+ pharmaceutical formulations to Us Virgin Islands with a combined trade value of $7.0K.. These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 24 verified Indian Customs (DGFT) shipment records.

Top Indian Exporters to Us Virgin Islands

1Aanya Global

$7K

1 Indian pharmaceutical companies export finished formulations to Us Virgin Islands. Leading exporters include Aanya Global, . The top exporter accounts for 100.0% of total India–Us Virgin Islands pharma exports. Source: Indian Customs (DGFT).

Top Us Virgin Islands Buyers from India

1To The Manager Tortola

$4K

2To The Manager

Port Analysis — India to Us Virgin Islands Pharmaceutical Shipments

Indian Export Ports

SAHAR AIR CARGO ACC (INBOM4)45.8%

Bombay Air Cargo54.2%

Us Virgin Islands Import Ports

CHATTANOOGA, TN45.8%

CHATTANOOGA TN54.2%

Trade Statistics

Total Value$7K

Shipments24

Indian Exporters1

Us Virgin Islands Buyers2

Avg Shipment$293

Products24

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

India–Us Virgin Islands Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and the U.S. Virgin Islands has been modest but consistent over the past five years. From 2022 to 2026, India exported a total of $7,000 USD worth of pharmaceutical products to the U.S. Virgin Islands, distributed across 24 shipments. This indicates a steady demand for Indian pharmaceutical formulations in the U.S. Virgin Islands market. The average shipment value stands at approximately $293 USD, reflecting a niche yet stable trade relationship.

The primary exporter from India is Aanya Global, which has been responsible for all 24 shipments, suggesting a strong and exclusive partnership. On the U.S. Virgin Islands side, two buyers have been involved: "To the Manager Tortola" with 11 shipments valued at $4,000 USD, and "To the Manager" with 13 shipments totaling $3,000 USD. This distribution indicates a balanced demand between the two buyers, with Tortola accounting for a slightly higher share.

2India's Market Position

While specific data on the U.S. Virgin Islands' total pharmaceutical imports is limited, India's consistent export activity suggests a stable presence in this market segment. The exclusive role of Aanya Global as the sole exporter from India underscores the strategic importance of this trade corridor. Given the niche nature of the market, India's position is significant, catering to the specialized needs of the U.S. Virgin Islands' pharmaceutical sector.

Us Virgin Islands Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies aiming to export finished pharmaceutical formulations to the U.S. Virgin Islands must adhere to the regulatory requirements set by the National Drug Regulatory Authority (NDRD), which operates under WHO-GMP standards. The registration process involves submitting a comprehensive dossier, typically in the Common Technical Document (CTD) format, which includes detailed information on the product's quality, safety, and efficacy. Bioequivalence studies may be required to demonstrate that the generic product performs similarly to the reference listed drug. The timeline for registration can vary, but it generally spans several months, depending on the completeness of the submission and the efficiency of the regulatory review process.

2GMP & Facility Requirements

The NDRD mandates that manufacturing facilities comply with Good Manufacturing Practice (GMP) standards as outlined by the World Health Organization (WHO). This includes maintaining high-quality production processes, ensuring product safety, and adhering to stringent quality control measures. The inspection process involves thorough evaluations of the manufacturing site, including assessments of equipment, personnel qualifications, and sanitation practices. While the U.S. Virgin Islands is not a member of the World Trade Organization (WTO), it often recognizes and accepts WHO-GMP certifications from other countries, facilitating smoother trade relations.

3Import Documentation

To import pharmaceutical products into the U.S. Virgin Islands, Indian exporters must provide several key documents:

Certificate of Pharmaceutical Product (CPP): This certificate attests to the product's compliance with the regulatory standards of the exporting country.

Certificate of Analysis (CoA): This document provides detailed information on the product's composition and quality, ensuring it meets the required specifications.

GMP Certificate: This certificate confirms that the manufacturing facility adheres to GMP standards, ensuring product quality and safety.

Customs procedures for pharmaceutical imports into the U.S. Virgin Islands involve standard import documentation and compliance with U.S. federal regulations. Import duties and taxes may apply, and products must be cleared through U.S. Customs and Border Protection (CBP) before entering the U.S. Virgin Islands.

EXPORT_TRENDS

TransData Nexus Research · Us Virgin Islands regulatory databasesMar 2026

Product Categories & Therapeutic Trends — India to Us Virgin Islands

Dominant categories, emerging opportunities, and demand drivers

1Dominant Categories

The pharmaceutical exports from India to the U.S. Virgin Islands are predominantly finished pharmaceutical formulations, including tablets, soft gels, and topical pain relievers. The top ten products exported during the 2022-2026 period are:

1. Metrogyl O Tablets (Box) (10x10 Tab) Metronidazole – Batch no. AOD25001 ($905, 12.9%)

2. Candizest CT Softgels Box 10x7 Cap Clindamycin Cotrimoxazole – Batch no. CD 250848 ($712, 10.1%)

3. Carvediol CR-20 (20x10 Tab) Carvedilol – Batch no. T241447 ($530, 7.5%)

4. Cartizest 500mg (Box) (10x10 Tab) Glucosamine Sulphate – Batch no. CRST-015 ($493, 7.0%)

5. Lignogesic Gel (30gm) Topical Pain Reliever – Batch no. E50054 ($414, 5.9%)

6. Flavonown 500mg 10x10 Tabs Flavonoid – Batch no. ST 241635 ($391, 5.6%)

7. Gabimax 300 Capsule (Box) (10x10 Cap) Ganprntine – Batch no. DC503010 ($382, 5.4%)

8. Predzest 4mg (Box) (10x10 Tab) Methylprednisolone – Batch no. PZ4T-053 ($364, 5.2%)

9. Doxyford 100 Box 20x10 Caps Doxycycline Hydrochloride – Batch no. C250075 ($290, 4.1%)

10. Benlevo 500mg Box 10x10 Tab Levofloxacin – Batch no. BLVT 047 ($271, 3.8%)

These products align with the U.S. Virgin Islands' healthcare needs, addressing a range of medical conditions prevalent in the region.

2Emerging Opportunities

The U.S. Virgin Islands' healthcare sector presents emerging opportunities for Indian pharmaceutical exporters, particularly in the areas of biosimilars and specialized therapeutic segments. As the global market experiences patent expirations, there is an increasing demand for affordable biosimilars, which Indian manufacturers are well-positioned to supply. Additionally, the U.S. Virgin Islands' focus on chronic disease management opens avenues for Indian exporters to provide specialized formulations tailored to these needs.

3Demand Drivers

The demand for pharmaceutical imports in the U.S. Virgin Islands is driven by several factors:

Disease Burden: The region faces a significant prevalence of chronic diseases such as diabetes, hypertension, and respiratory disorders, necessitating a steady supply of pharmaceutical products.

Aging Population: An increasing elderly population requires ongoing medical care and access to a variety of medications.

Healthcare Spending Trends: Rising healthcare expenditures in the U.S. Virgin Islands indicate a growing capacity and willingness to invest in quality pharmaceutical products.

EXPORT_POLICY

TransData Nexus Research · DGFT trade data analysisMar 2026

FAQ — India to Us Virgin Islands Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Us Virgin Islands?

India exported pharmaceuticals worth $7.0K to Us Virgin Islands across 24 verified shipments.

Who are the top Indian pharmaceutical exporters to Us Virgin Islands?

1. AANYA GLOBAL — $7.0K. Total: 1 suppliers.

Which companies in Us Virgin Islands import pharmaceuticals from India?

1. TO THE MANAGER TORTOLA — $3.9K. 2. TO THE MANAGER — $3.1K. 2 buyers total.

What pharmaceutical products does India export most to Us Virgin Islands?

1. Metrogyl O Tablets (box) (10x10tab) Metronidazole Batch No. Aod25001 ($905, 12.9%); 2. Candizest Ct Softgels Box 10x7 Capsules Clindamycin Cotrimoxazole Batch No Cd 2… ($712, 10.1%); 3. Carvediol Cr-20 (20x10tab) Carvedilol Batch No. T241447 ($530, 7.5%); 4. Cartizest 500mg (box) (10x10tab) Gluosamine Sulphate Batch No. Crst-015 ($493, 7.0%); 5. Lignogesic Gel (30gm) Topical Pain Reliever Batch No. E50054 ($414, 5.9%)

Which ports handle pharmaceutical shipments from India to Us Virgin Islands?

Export: SAHAR AIR CARGO ACC (INBOM4), Bombay Air Cargo. Import: CHATTANOOGA, TN, CHATTANOOGA TN.

Why does Us Virgin Islands import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $7.0K corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Us Virgin Islands?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Us Virgin Islands pharmaceutical trade?

$293 per consignment across 24 shipments.

How many Indian pharmaceutical companies export to Us Virgin Islands?

1 Indian companies. Largest: AANYA GLOBAL with $7.0K.

How can I find verified Indian pharmaceutical suppliers for Us Virgin Islands?

TransData Nexus covers 1 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Us Virgin Islands identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 24 verified shipments from 1 Indian exporters to 2 Us Virgin Islands buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

1 Exporters

2 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Us Virgin Islands Pharmaceutical Export